Dr Adam Knott

adam knott


Principal Clinical Development Scientist, Roche


Adam is a Principal Clinical Scientist in Pharma Development Clinical Science Oncology serving as the clinical science lead for the HER2 franchise and sitting on the Global Development Team.

Adam has been at Roche for 13 years which has included being the lead clinical scientist for the pertuzumab pivotal clinical trials CLEOPATRA and APHINITY, being a Senior Strategic Leader within the Personalised HealthCare Oncology group, acting as Welwyn Site Head for both Clinical Science Oncology and Personalised HealthCare, being a member of the Welwyn Leadership Team and sitting on the Portfolio Enabling Committee.